Trans Genic Inc. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,618
1,959
2,290
2,303
3,601
8,675
Cost of Goods Sold (COGS) incl. D&A
1,106
1,302
1,618
1,554
2,779
7,176
Gross Income
511
657
673
749
822
1,498
SG&A Expense
594
633
622
595
759
1,228
Unusual Expense
55
13
-
4
22
54
Non Operating Income/Expense
40
1
1
15
8
1
Interest Expense
2
2
8
1
10
7
Pretax Income
99
9
19
82
14
203
Consolidated Net Income
106
13
15
81
21
202
Net Income
114
18
15
81
21
202
Net Income After Extraordinaries
114
18
15
81
21
202
Net Income Available to Common
114
18
15
81
21
202
EPS (Basic)
8.39
1.29
1.05
5.63
1.41
11.95
Basic Shares Outstanding
14
14
14
14
15
17
EPS (Diluted)
8.39
1.29
1.05
5.62
1.39
11.91
Diluted Shares Outstanding
14
14
14
14
15
17
EBITDA
2
118
154
266
207
461
Non-Operating Interest Income
2
1
1
1
1
5
Minority Interest Expense
7
5
-
-
-
-
Equity in Affiliates (Pretax)
-
-
25
61
11
13
About Trans Genic
View Profile
